ARTICLE | Company News
Viragen, Cancer Research Technology Limited deal
May 16, 2005 7:00 AM UTC
VRA exercised an option to acquire exclusive worldwide development and marketing rights to Cancer Research's anti- CD55 antibody, which is in preclinical testing to treat cancer. ...